Literature DB >> 8309580

Altered pulsatile secretion of luteinizing hormone in women with epilepsy.

F W Drislane1, A E Coleman, D L Schomer, J Ives, L A Levesque, M M Seibel, A G Herzog.   

Abstract

Menstrual disorders and infertility are common among women with epilepsy of temporal lobe origin (TLE). Reproductive endocrine disorders may be the cause. Polycystic ovarian syndrome (PCO) and hypothalamic amenorrhea (hypogonadotropic hypogonadism, HH), in particular, are significantly overrepresented and attributable to hypothalamic dysfunction. We therefore compared the hypothalamic function of 14 women with clinically and electrographically documented TLE with that of eight age-matched normal controls by determining the interictal pulse frequency and amplitude of luteinizing hormone (LH) secretion. Serum for LH measurement was drawn every 15 minutes from 8 AM to 4 PM in both groups. LH pulse frequency values were significantly more variable (p < 0.05) and lower (p < 0.05) among women with TLE than among controls. Women with left temporal EEG foci showed a trend toward higher pulse frequencies compared to women with right foci (p = 0.05 to 0.10). Among five women with reproductive endocrine disorders, the three with PCO had left-sided foci and average LH pulse frequency two times higher than that of the two women with HH, who had right-sided foci. Eight reproductively normal, medically treated women with TLE had significantly lower LH pulse frequencies than did the one reproductively normal, untreated woman with TLE (p < 0.05) and the eight normal controls (p < 0.001). These findings suggest that LH pulse frequencies in women with TLE may be influenced by the laterality of the epileptic focus, the reproductive endocrine status, and the use of antiseizure medications.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8309580     DOI: 10.1212/wnl.44.2.306

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  13 in total

Review 1.  Sex and hormonal influences on seizures and epilepsy.

Authors:  Jana Velíšková; Kara A Desantis
Journal:  Horm Behav       Date:  2012-04-04       Impact factor: 3.587

2.  Polycystic ovaries and polycystic ovary syndrome in epilepsy: evidence for neurogonadal disease.

Authors:  Cynthia L Harden
Journal:  Epilepsy Curr       Date:  2005 Jul-Aug       Impact factor: 7.500

Review 3.  Functional significance of the innervation of the gonads.

Authors:  Ida Gerendai; Péter Banczerowski; Béla Halász
Journal:  Endocrine       Date:  2005-12       Impact factor: 3.633

Review 4.  Epilepsy, depression, and growth hormone.

Authors:  Tracy Butler; Patrick Harvey; Lila Cardozo; Yuan-Shan Zhu; Adam Mosa; Emily Tanzi; Fahad Pervez
Journal:  Epilepsy Behav       Date:  2019-02-14       Impact factor: 2.937

Review 5.  Neuroendocrine considerations in the treatment of men and women with epilepsy.

Authors:  Cynthia L Harden; Page B Pennell
Journal:  Lancet Neurol       Date:  2013-01       Impact factor: 44.182

6.  Sex differences in brain gray and white matter in healthy young adults: correlations with cognitive performance.

Authors:  R C Gur; B I Turetsky; M Matsui; M Yan; W Bilker; P Hughett; R E Gur
Journal:  J Neurosci       Date:  1999-05-15       Impact factor: 6.167

7.  Menstrual cycle and ovary alterations in women with epilepsy on antiepileptic therapy.

Authors:  G Murialdo; C A Galimberti; F Magri; P Sampaolo; F Copello; M V Gianelli; E Gazzerro; A Rollero; C Deagatone; R Manni; E Ferrari; A Polleri; A Tartara
Journal:  J Endocrinol Invest       Date:  1997-10       Impact factor: 4.256

Review 8.  Polycystic ovary syndrome and epilepsy: a review of the evidence.

Authors:  Roberta Meo; Leonilda Bilo
Journal:  Drugs       Date:  2003       Impact factor: 9.546

9.  Seizures and reproductive function: insights from female rats with epilepsy.

Authors:  Helen E Scharfman; Michelle Kim; Tana M Hintz; Neil J MacLusky
Journal:  Ann Neurol       Date:  2008-12       Impact factor: 10.422

Review 10.  Sex Differences in the Epilepsies and Associated Comorbidities: Implications for Use and Development of Pharmacotherapies.

Authors:  Catherine A Christian; Doodipala Samba Reddy; Jamie Maguire; Patrick A Forcelli
Journal:  Pharmacol Rev       Date:  2020-10       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.